Operating CF
$4.42B
Capex
−$91.10M
Free Cash Flow
$4.33B
FCF Margin
+97.9%
Cash flow waterfall for CME Group (CME) — TTM through Q1 2026
Free cash flow: $4.33B
Cash flow breakdown for CME Group (CME) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Operating Cash Flow | $4.42B | $4.42B |
| Capital Expenditure | −$91.10M | $4.33B |
| Free Cash Flow | $4.33B | $4.33B |
| Acquisitions | $1.58B | $5.91B |
| Other Investing | $100.00K | $5.91B |
| Share Buybacks | −$796.60M | $5.12B |
| Dividends Paid | −$4.06B | $1.05B |
| Other Financing & FX | $44.27B | $45.33B |
| Net Cash Increase | $45.33B | $45.33B |
- Operating Cash Flow$4.42B
- Capital Expenditure−$91.10M
- Free Cash Flow$4.33B
- Acquisitions$1.58B
- Other Investing$100.00K
- Share Buybacks−$796.60M
- Dividends Paid−$4.06B
- Other Financing & FX$44.27B
- Net Cash Increase$45.33B
Want to see what drove the FCF change?Free Cash Flow Bridge
Frequently asked questions
Data & methodology
CME Group (CME) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Profitability
Cash Flow
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement